Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol SEMG1 contributors: mct - updated : 13-02-2018
HGNC name semenogelin I
HGNC id 10742
Location 20q13.12      Physical location : 43.835.637 - 43.838.414
Synonym name
  • semen coagulating protein
  • cancer/testis antigen
  • Synonym symbol(s) SEMG, MGC14719, SGI, CT103, dJ172H20.2
    DNA
    TYPE functioning gene
    SPECIAL FEATURE arranged in tandem
    text located 5' to SEMG2 in a head to tail arrangement
    STRUCTURE 2.80 kb     3 Exon(s)
    10 Kb 5' upstream gene genomic sequence study
    MAPPING cloned Y linked N status confirmed
    regionally located tightly linked to SEMG2
    RNA
    TRANSCRIPTS type messenger
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    3 - 1696 - 462 - 2013 24312623
    EXPRESSION
    Type restricted
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Reproductivemale systemseminal vesicles  highly
     male systemmale genital tractepididymis  
     male systemprostate   
     male systemmale genital tractvas deferens  
    Respiratoryrespiratory tracttrachea   
    tissue
    SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
    Muscularstriatumskeletal  
    cell lineage
    cell lines
    fluid/secretion in human semen coagulum
    at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
    HOMOLOGY
    interspecies homolog to murine Syp1
    Homologene
    FAMILY semenogelin family
    CATEGORY secretory
    SUBCELLULAR LOCALIZATION extracellular
        intracellular
    intracellular,nucleus
    basic FUNCTION
  • formation of a gel matrix entrapping the accessory gland secretion and ejaculated spermatozoa
  • antibacterial activity of the SEMG1-derived peptides generated in seminal plasma was strictly zinc-dependent both at neutral and low pH
  • in sperm modifies the membrane structure, indirectly inhibiting motility
  • EPPIN and SEMG1 rapidly co-evolved in primates due to their critical role in the modulation of sperm motility in the semen coagulum
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component major constituent protein of seminal fluid
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • rapidly cleaved after ejaculation by KLK3, resulting in liquefaction of the semen coagulum and
  • the progressive release of motile spermatozoa
  • binding semenogelins II and zinc and regulate the activity of prostate-specific antigen (KLK3)
  • cleaved by KLK14
  • during ejaculation SEMG (semenogelin) from the seminal vesicles binds to the EPPIN protein complex, initiating a series of events that define EPPIN function
  • EPPIN controls sperm motility in the ejaculate by binding SEMG1, resulting in the loss of calcium, most likely through a disturbance of internal pH and an inhibition of uptake mechanisms
  • EPPIN's sequence C102-P133 contains the major binding site for SEMG1
  • interaction between PIP and SEMG1 fragments in seminal plasma or elsewhere with a suggestive role in reproductive physiology which might be helpful for spermatozoa to acquire their motility
  • physiological significance of the SEMG1/EPPIN interaction on the surface of spermatozoa is its capacity to modulate sperm progressive motility
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in nearly half of patients with early Chronic lymphocytic leukemia (CLL)
    Susceptibility
    Variant & Polymorphism
    Candidate gene
  • candidate gene for the development of diagnostic marker and provided the opportunity to further illustrate the biological mechanisms of asthenozoosperm
  • Marker
  • use of SEMG1 as a novel biomarker for renal cell carcinoma
  • Therapy target
    ANIMAL & CELL MODELS